Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KetoPrime is a nutritional supplement developed by MetVital that contains a low dose of oxaloacetate (oxaloacetic acid). Oxaloacetate is a key metabolic intermediate in the citric acid cycle (Krebs cycle), where it reacts with acetyl-CoA to form citrate, a critical step in cellular energy production. As a supplement, KetoPrime is marketed for general wellness and is intended to support mitochondrial function and metabolic health. It is positioned as a calorie restriction mimetic, potentially influencing the NAD+/NADH ratio to support cellular longevity and energy levels. While MetVital is developing higher-dose oxaloacetate formulations for clinical indications such as cancer, KetoPrime is currently available as an approved nutritional product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KetoPrime.